Third-party regulatory T cells prevent murine acute graft-versus-host disease

BACKGROUND/AIMS: Adoptive therapy with regulatory T (Treg) cells to prevent graft-versus-host disease (GVHD) would benefit from a strategy to improve homing to the sites of inflammation following hematopoietic stem cell transplantation (HSCT). Although donor-derived Treg cells have mainly been used...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Jung-Yeon, Im, Keon-Il, Song, Yunejin, Kim, Nayoun, Nam, Young-Sun, Jeon, Young-Woo, Cho, Seok-Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129628/
https://www.ncbi.nlm.nih.gov/pubmed/29050459
http://dx.doi.org/10.3904/kjim.2016.319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129628/
https://www.ncbi.nlm.nih.gov/pubmed/29050459
http://dx.doi.org/10.3904/kjim.2016.319

Ejemplares similares